Cancer BiologybioRxiv
CAR-T Engager Proteins Optimize Anti-CD19 CAR-T Cell Therapies for Lymphoma
L. Su, L. Wu, R. R. Lobb…·C. Ambrose
This paper introduces a CAR-T Engager protein that prevents and reverses lymphoma relapse by maintaining CD19 antigen presence on cancer cells.
DOI 10.1080/2162402x.2022.2111904